30 related articles for article (PubMed ID: 17577799)
1. Treatment of primary central nervous system lymphoma with induction of complement-dependent cytotoxicity by intraventricular administration of autologous-serum-supplemented rituximab.
Takami A; Hayashi T; Kita D; Nishimura R; Asakura H; Nakao S
Cancer Sci; 2006 Jan; 97(1):80-3. PubMed ID: 16367925
[TBL] [Abstract][Full Text] [Related]
2. Management of elderly patients with primary central nervous system lymphoma.
Daras M; DeAngelis LM
Curr Neurol Neurosci Rep; 2013 May; 13(5):344. PubMed ID: 23564069
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation.
Lieberman F; Yazbeck V; Raptis A; Felgar R; Boyiadzis M
J Neurooncol; 2012 Apr; 107(2):225-32. PubMed ID: 22037801
[TBL] [Abstract][Full Text] [Related]
4. A successful treatment of relapsed primary CNS lymphoma patient with intraventricular rituximab followed by high-dose chemotherapy with autologous stem cell rescue.
Hong SJ; Kim JS; Chang JH; Kim KM; Kim SJ; Lee HW; Cheong JW; Lee ST; Min YH
Yonsei Med J; 2009 Apr; 50(2):280-3. PubMed ID: 19430564
[TBL] [Abstract][Full Text] [Related]
5. Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab.
Pels H; Schulz H; Manzke O; Hom E; Thall A; Engert A
J Neurooncol; 2002 Sep; 59(3):213-6. PubMed ID: 12241117
[TBL] [Abstract][Full Text] [Related]
6. Intra-CSF rituximab for lymhomatous meningitis.
Chamberlain MC; Glantz MJ
J Clin Oncol; 2007 Oct; 25(28):4508-9; author reply 4509-11. PubMed ID: 17906219
[No Abstract] [Full Text] [Related]
7. Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.
Jahnke K; Muldoon LL; Varallyay CG; Lewin SJ; Brown RD; Kraemer DF; Soussain C; Neuwelt EA
Neuro Oncol; 2009 Oct; 11(5):503-13. PubMed ID: 19158414
[TBL] [Abstract][Full Text] [Related]
8. Successful use of intraventricular and intravenous rituximab therapy for refractory primary CNS lymphoma in a child.
Akyuz C; Aydin GB; Cila A; Akalan N; Soylemezoglu F; Cengiz M; Yazici N; Buyukpamukcu M
Leuk Lymphoma; 2007 Jun; 48(6):1253-5. PubMed ID: 17577799
[No Abstract] [Full Text] [Related]
9. Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: experience with two cases and review of the literature.
Pels H; Schulz H; Schlegel U; Engert A
Onkologie; 2003 Aug; 26(4):351-4. PubMed ID: 12972702
[TBL] [Abstract][Full Text] [Related]
10. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
Enting RH; Demopoulos A; DeAngelis LM; Abrey LE
Neurology; 2004 Sep; 63(5):901-3. PubMed ID: 15365145
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
